Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Pharmacol Res 1998;37(2):115-122
NHS prescribing follows type 2 diabetes guidelines (NICE NG28), with GLP-1 receptor agonists like Rybelsus reserved for patients meeting specific BMI and clinical criteria alongside inadequate glycaemic control on metformin
PlexusDx check-ins at week 2 and week 4 assess your adaptation, adjust fluid intake and meal timing if needed, and confirm that your dose trajectory remains on track for your weight loss goals
Additionally, Metformin is recognized as a cheaper and cost-effective substitute for Trulicity
Current GLP-1-based treatments, including exenatide, liraglutide, dulaglutide, semaglutide, and tirzepatide, offer varying pharmacokinetic profiles that allow for once-daily or once-weekly dosing, improving patient adherence
